Oncolytic Newcastle disease virus activation of the innate immune response and priming of antitumor adaptive responses in vitro
/in International Publications, Newcastle Disease VirusImmunotherapy for mesothelioma: a critical review of current clinical trials and future perspectives
/in Dendritic Cells, International Publications, Malignant Pleural Mesothelioma, Newcastle Disease VirusTargeting aerobic glycolysis by dichloroacetate improves Newcastle disease virus-mediated viro-immunotherapy in hepatocellular carcinoma
/in Hepatocellular Carcinoma, International Publications, Newcastle Disease VirusEvaluation of Newcastle disease virus mediated dendritic cell activation and cross-priming tumor-specific immune responses ex vivo
/in Breast Cancer, Dendritic Cells, International Publications, Newcastle Disease VirusEvaluation of a Recombinant Newcastle Disease Virus Expressing Human IL12 against Human Breast Cancer
/in Breast Cancer, International Publications, Newcastle Disease Virus2-Deoxyglucose and Newcastle Disease Virus Synergize to Kill Breast Cancer Cells by Inhibition of Glycolysis Pathway Through Glyceraldehyde3-Phosphate Downregulation
/in Breast Cancer, International Publications, Newcastle Disease VirusPast, Current, and Future of Immunotherapies for Prostate Cancer
/in Checkpoint-Inhibitors, Dendritic Cells, International Publications, Newcastle Disease Virus, Prostate CancerThe current state of immunotherapy for gliomas: an eye toward the future
/in Dendritic Cells, Glioblastoma, International Publications, Newcastle Disease VirusBreaking Therapy Resistance: An Update on Oncolytic Newcastle Disease Virus for Improvements of Cancer Therapy
/in Checkpoint-Inhibitors, Dendritic Cells, International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de